Patent · US Active

Phthalazines as potassium ion channel inhibitors

US9242966B2 · kind B2 · utility

3Cited by

2References

17Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Heather Finlay · Skillman, US
Ashok Kumar Adisechan · Puducherry, IN
Prashantha Gunaga · Savanuru, IN
John Lloyd · Yardley, US
Pothukanuri Srinivasu · Bengaluru, IN

Key dates

Filing date	Mar 7, 2014
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Mar 7, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I)wherein A, R1, R3, and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.